| Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach AK Krug, R Kolde, JA Gaspar, E Rempel, NV Balmer, K Meganathan, ... Archives of toxicology 87, 123-143, 2013 | 249 | 2013 |
| Toxicokinetic triage for environmental chemicals JF Wambaugh, BA Wetmore, R Pearce, C Strope, R Goldsmith, JP Sluka, ... Toxicological Sciences 147 (1), 55-67, 2015 | 170 | 2015 |
| Evaluation of an alternative in vitro test battery for detecting reproductive toxicants AH Piersma, S Bosgra, MBM Van Duursen, SAB Hermsen, LRA Jonker, ... Reproductive Toxicology 38, 53-64, 2013 | 105 | 2013 |
| An improved model to predict physiologically based model parameters and their inter-individual variability from anthropometry S Bosgra, J van Eijkeren, P Bos, M Zeilmaker, W Slob Critical reviews in toxicology 42 (9), 751-767, 2012 | 89 | 2012 |
| An integrated probabilistic framework for cumulative risk assessment of common mechanism chemicals in food: an example with organophosphorus pesticides S Bosgra, H van der Voet, PE Boon, W Slob Regulatory Toxicology and Pharmacology 54 (2), 124-133, 2009 | 86 | 2009 |
| Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery B Zimmer, G Pallocca, N Dreser, S Foerster, T Waldmann, J Westerhout, ... Archives of toxicology 88, 1109-1126, 2014 | 79 | 2014 |
| Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling J Louisse, S Bosgra, BJ Blaauboer, IMCM Rietjens, M Verwei Archives of toxicology 89, 1135-1148, 2015 | 75 | 2015 |
| Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein … S Bosgra, E van de Steeg, ML Vlaming, KC Verhoeckx, MT Huisman, ... European Journal of Pharmaceutical Sciences 65, 156-166, 2014 | 73 | 2014 |
| Availability of polychlorinated biphenyls (PCBs) and lindane for uptake by intestinal Caco-2 cells. AG Oomen, J Tolls, M Kruidenier, SS Bosgra, AJ Sips, JP Groten Environmental Health Perspectives 109 (7), 731-737, 2001 | 56 | 2001 |
| An expert consortium review of the EC-commissioned report" Alternative (Non-Animal) Methods for Cosmetics Testing: Current Status and Future Prospects-2010". T Hartung, BJ Blaauboer, S Bosgra, E Carney, J Coenen, RB Conolly, ... ALTEX 28 (3), 183, 2011 | 54 | 2011 |
| A model for probabilistic health impact assessment of exposure to food chemicals H van der Voet, GWAM van der Heijden, PMJ Bos, S Bosgra, PE Boon, ... Food and Chemical Toxicology 47 (12), 2926-2940, 2009 | 49 | 2009 |
| Probabilistic cumulative risk assessment of anti-androgenic pesticides in food AK Müller, S Bosgra, PE Boon, H van der Voet, E Nielsen, O Ladefoged Food and Chemical Toxicology 47 (12), 2951-2962, 2009 | 47 | 2009 |
| Probabilistic risk characterization: an example with di (2-ethylhexyl) phthalate S Bosgra, PMJ Bos, TG Vermeire, RJ Luit, W Slob Regulatory Toxicology and Pharmacology 43 (1), 104-113, 2005 | 47 | 2005 |
| Evaluation of an alternative in vitro test battery for detecting reproductive toxicants in a grouping context ED Kroese, S Bosgra, HE Buist, G Lewin, SC van der Linden, H Man, ... Reproductive Toxicology 55, 11-19, 2015 | 44 | 2015 |
| Suppression of mutant protein expression in SCA3 and SCA1 mice using a CAG repeat-targeting antisense oligonucleotide E Kourkouta, R Weij, A González-Barriga, M Mulder, R Verheul, S Bosgra, ... Molecular Therapy-Nucleic Acids 17, 601-614, 2019 | 42 | 2019 |
| Probabilistic modelling of exposure doses and implications for health risk characterization: Glycoalkaloids from potatoes J Ruprich, I Rehurkova, PE Boon, K Svensson, S Moussavian, ... Food and chemical toxicology 47 (12), 2899-2905, 2009 | 41 | 2009 |
| Human glycemic response curves after intake of carbohydrate foods are accurately predicted by combining in vitro gastrointestinal digestion with in silico kinetic modeling S Bellmann, M Minekus, P Sanders, S Bosgra, R Havenaar Clinical Nutrition Experimental 17, 8-22, 2018 | 35 | 2018 |
| To apply microdosing or not? Recommendations to single out compounds with non-linear pharmacokinetics S Bosgra, MLH Vlaming, WHJ Vaes Clinical pharmacokinetics 55, 1-15, 2016 | 32 | 2016 |
| Dose addition and the isobole method as approaches for predicting the cumulative effect of non-interacting chemicals: A critical evaluation S Bosgra, JCH van Eijkeren, W Slob Critical Reviews in Toxicology 39 (5), 418-426, 2009 | 28 | 2009 |
| The Pharmacokinetics of 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides: Experiences from Developing Exon Skipping Therapies for Duchenne … S Bosgra, J Sipkens, S de Kimpe, C den Besten, N Datson, ... nucleic acid therapeutics 29 (6), 305-322, 2019 | 26 | 2019 |
